French Tech Côte d’Azur presents the selected Côte d’Azur startups for the 2023 edition of the Scale Up Excellence program.
The 2023 promotion of the “Scale Up Excellence” program includes 48 startups in hypergrowth, selected based on criteria attesting to their strong growth. Among the 5 French Tech Capitals leading the program, French Tech Côte d’Azur has 12 startups selected for this promotion, which attests to the vitality of the entrepreneurial ecosystem of the Côte […]
The Jean-Louis Noisiez Heart Institute will be inaugurated in 2027
This new center of excellence in cardiology is the result of a joint initiative by Dr. Jean-Marie Salvadori and Mr. Jean-Louis Noisiez, a philanthropist who passed away in November 2022 and had already created a foundation to help patients with Alzheimer’s disease and their caregivers. This ambitious project, integrated into the Arnault-Tzanck Institute in Saint-Laurent-du-Var […]
Labeling of 55 competitiveness clusters in France and 7 for the South Region
The French government has announced the labeling of 55 competitiveness clusters for Phase V (2023-2026) at the General Assembly of the French Association of Competitiveness Clusters (AFPC) in the presence of Roland Lescure, Delegate Minister for Industry, Harold Huwart, representative of Regions of France, Bruno Le Maire, Minister of the Economy, Finance and Industrial and […]
Virbac accelerates its commercial development in the United States
Virbac officially announces the appointment of Giovanni Abruzzini as the new President and CEO of Virbac North America, effective from March 27, 2023. His primary objective will be to develop the company’s North American commercial activities in accordance with the overall strategy of the Virbac group. Giovanni Abruzzini, who has extensive experience in the healthcare […]
Nice: Inauguration of the new Oral Medicine Institute at the Nice University Hospital (CHU de Nice)
The city of Nice benefits from a new state-of-the-art facility with the inauguration of the Oral Medicine Institute at the Nice University Hospital (CHU de Nice) on February 28th. The Institute occupies a fully renovated 3600 m² building located at 28 Boulevard de Riquier in Nice, near the dental school. This new building enables the […]
Nice: Biotech ExAdex-Innov explores the therapeutic potential of human adipose tissue
ExAdEx-Innov, a biotechnology company based in Nice within the bio-incubator of the Institute of Biology Valrose (IBV), is developing a revolutionary technology to explore the potential therapeutic properties of human adipose tissue. ExAdEx Innov: addressing a major public health challenge Metabolic diseases associated with obesity affect nearly one billion people worldwide, a number that is […]
French Tech Côte d’Azur: “Capital” label renewed for 3 years
The French Tech Mission has renewed the label of the French Tech Capital for the French Tech Côte d’Azur in the Sud Region for a duration of three years (2023-2025), confirming the vibrant nature of the technological ecosystem of the Côte d’Azur Alongside 15 other labeled capitals, the operational teams of French Tech Côte d’Azur […]
Bewellthy-Bewellconnect sets up in Nice
The group specializing in connected health services settles in the Grand Arénas business district, within Nice Ecovallée, to pursue its international development. Interview with Rodolphe Bioche, CEO of Bewellthy-BewellConnect Can you present your company and its activities? Our Bewellthy-Bewellconnect group is a leading player in the field of telemedicine services and related services. We design […]
AlgenScribe settles in Nice Côte d’Azur Metropolis
AlgenScribe is a biotechnology company that develops a genome editing platform for the implementation of gene therapies. The company has chosen Nice to develop its activities. Interview with Frédéric ZAMPATTI, co-founder and CEO of AlgenScribe. Can you tell us about your company and your activities? With the creation of AlgenScribe, we aim to harness the […]
Roca Therapeutics completes seed funding round
Roca Therapeutics, based in Nice, is a leading biotech startup specialized in the discovery and development of small molecules addressing severe life-threatening disorders caused by hypervascularization and macrophages M2 driven immunosuppression. The company announced the closing of a seed funding round led by 3B Future Health Fund II and SATT Sud-Est. Roca Therapeutics will use these funds to […]
